Saturday, March 04, 2006


Ways You Can Get Infected With Hepatitis C(NC)-Hepatitis (Hep C Treatment)

Ways You Can Get Infected With Hepatitis C

(NC)-Hepatitis C is spread through contact with infected blood. Here are just some of the ways in which you can be infected with this virus:

Sharing needles, straws, pipes, spoons and other drug-related equipment.

(At least two-thirds of all new hepatitis C infections are drug-use related. Cleaning equipment with bleach does not always effectively kill the virus) p>

Getting a tattoo, body piercing or acupuncture from an operator who does not use sterile equipment or techniques

Being born to a mother with hepatitis C

Getting pierced by a needle or sharp equipment that has infected blood on it ( in a hospital, workplace situation, etc.) p>

People who had blood transfusions before the testing of blood donations became mandatory in 1990 may also be at risk. And, while the risk is low, it is also possible to become infected by sharing personal household articles such as a razor or toothbrush with an infected person. The risk of transmission of hepatitis C during sex is also low, unless both parties have open bleeding sores.

It is estimated that 240, 000 people in Canada are currently infected with hepatitis C, of whom only 30% know they have the virus.

If you think you may be at risk, either now or from past risky activities see a doctor. The virus can be detected with a simple blood test, and there are steps and medications you can take to successfully minimize the effects of the disease if your diagnosis is positive. For more information, visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.


Friday, March 03, 2006


Is There A Vaccine For Hepatitis C?(NC)-No, not (Hep C Treatment)

Is There A Vaccine For Hepatitis C?

(NC)-No, not for hepatitis C. There are vaccines for hepatitis A and hepatitis B. To prevent further damage to your liver, your doctor may advise you to be vaccinated against hepatitis A and hepatitis B.

Could I give hepatitis C to someone else?

Yes, as far as we know, once you have hepatitis C, you can always transmit it to someone else if they come in contact with your blood. If you have hepatitis C, you can't donate blood. You should avoid sharing personal items like razors and toothbrushes, because the virus is spread through blood to blood contact.

Although the virus isn't spread easily by sexual contact or from a mother to her unborn baby, the risk of transmitting the virus is not absent. Therefore, talk to your doctor first if you want to have children. p>

For more information on hepatitis C visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.



'Silent killer' driven out of the shadows: Hepatitis (Hep C Treatment)


'Silent killer' driven out of the shadows: Hepatitis
Chillicothe Gazette - Feb 20 4:39 AM
There was a time when Arline Loh of Wilmington, Del., didn't tell people she has hepatitis B. "It carries such a stigma," says Loh, 57, an information technology expert who retired three months ago because of liver damage caused by the disease.Save to My Web

Proposal to give free pipes to crack addicts
The Scotsman: Health - Feb 08 5:15 PM
ADDICTS who smoke crack cocaine could be given free pipes at the taxpayers' expense to prevent the spread of tuberculosis and other diseases.Save to My Web

Local News Hepatitis C - silent epidemic
Thunder Bay Post - Feb 23 1:30 PM
It's being called the silent epidemic by those that deal with it on a day to day basis. The incidence of Hepatitis C is rising in Northwestern Ontario, and alarmingly, at a much higher rate than the rest of the province.Save to My Web

ARROW THERAPEUTICS SELECTS HEP C CLINICAL CANDIDATE
Asia Pulse via Yahoo! Australia & NZ Finance - Feb 05 11:55 PM
Technology Save to My Web

Cirrhosis Of The Liver (Hep C Treatment)


Cirrhosis Of The Liver
Title: Cirrhosis Of The LiverCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 12/1/2005

Alcoholism Facts
Title: Alcoholism FactsCategory: Health FactsCreated: 8/9/2005Last Editorial Review: 8/29/2005

Immunization: National Immunization Awareness Month
Title: Immunization: National Immunization Awareness MonthCategory: Health FactsCreated: 8/1/2005Last Editorial Review: 8/1/2005

How to Choose a Doctor
Title: How to Choose a DoctorCategory: Doctor's ViewsCreated: 6/17/2005Last Editorial Review: 8/9/2005

Help Stop AIDS & Hepatitis C (Hep C Treatment)


Help Stop AIDS & Hepatitis C
You can download fact sheets and FAQ's on the Centers for Disease Control and Prevention's Viral Hepatitis C information page

Hepatic Pathology Index
Viral hepatitis, liver, gross Viral hepatitis, liver, gross Viral hepatitis B, liver, low power microscopic Viral hepatitis B, liver, high power microscopic [IPX] Viral hepatitis C, liver, high power

Health Topic: V
VEGETARIAN DIET VENTRICULAR SEPTAL DEFECT VERTEBRAL COMPRESSION FRACTURE VERTICAL BANDED GASTROPLASTY VERTIGO VIRAL HEMORRHAGIC FEVERS VIRAL HEPATITIS A VIRAL HEPATITIS B VIRAL HEPATITIS C VIRAL

Review of Pathology of the Liver:Table of Contents
li-5-3 Viral hepatitis B li-5-4 Viral hepatitis C li-5-5 Viral hepatitis D li-5-6 Viral hepatitis E li-5-7 Viral hepatitis F li-5-8 Viral hepatitis G

Hepatitis C -- References
Viral hepatitis C fact sheet. Available at: www.cdc.gov/ncidod/disease/hepatitis/c/fact.htm. Accessed September 20, 2004. Lauer GM, Walker BD

HEPATITIS C TREATMENT
in Russia using soy bean phosphatidylcholine and glycyrrhizin from licorice roots. This selected combination, currently being used in Russia for the treatment of acute and chronic viral Hepatitis C

Broad Hep C push works (Hep C Treatment)


Broad Hep C push works
Age - GIVING free syringes, safety tips and health care to drug users in a broad strategy to curb Australia's hepatitis C epidemic is up to three times more cost-effective than funding only prevention and education programs. Secret research commissioned by

Daily Planner: Monday
Chico Enterprise-Record - SIERRA NEVADA BREWING CO.'s BIG ROOM: 7:30 p.m. Live Irish music by Patrick Street. Benefit for KZFR 90.1 FM. $20 in the pub or by calling 345-2739. A dinner priced at $10 will be available from 6 p.m. until show time. MIKELESS OPEN MIKE: 8 p.m., Has

Health calendar
Asheville Citizen-Times - Send items for the health calendar at least two weeks in advance to Health Calendar, Asheville Citizen-Times, P.O. Box 2090, Asheville, NC 28802; fax to 251-0585, or e-mail them to Jason Sandford at jsandford@CITIZEN-TIMES.com . WNC BRAIN INJURY

'Silent killer' driven out of the shadows: Hepatitis
Chillico Gazette - There was a time when Arline Loh of Wilmington, Del., didn't tell people she has hepatitis B. "It carries such a stigma," says Loh, 57, an information technology expert who retired three months ago because of liver damage caused by the disease

Thursday, March 02, 2006


Health calendar (Hep C Treatment)


Health calendar
Asheville Citizen-Times - Send items for the health calendar at least two weeks in advance to Health Calendar, Asheville Citizen-Times, P.O. Box 2090, Asheville, NC 28802; fax to 251-0585, or e-mail them to Jason Sandford at jsandford@CITIZEN-TIMES.com . WNC BRAIN INJURY

Broad Hep C push works
Age - GIVING free syringes, safety tips and health care to drug users in a broad strategy to curb Australia's hepatitis C epidemic is up to three times more cost-effective than funding only prevention and education programs. Secret research commissioned by

Daily Planner: Monday
Chico Enterprise-Record - SIERRA NEVADA BREWING CO.'s BIG ROOM: 7:30 p.m. Live Irish music by Patrick Street. Benefit for KZFR 90.1 FM. $20 in the pub or by calling 345-2739. A dinner priced at $10 will be available from 6 p.m. until show time. MIKELESS OPEN MIKE: 8 p.m., Has

'Silent killer' driven out of the shadows: Hepatitis
Chillico Gazette - There was a time when Arline Loh of Wilmington, Del., didn't tell people she has hepatitis B. "It carries such a stigma," says Loh, 57, an information technology expert who retired three months ago because of liver damage caused by the disease


NIDA - NIDA Community Drug Alert Bulletin - Hepatitis (Hep C Treatment)


NIDA - NIDA Community Drug Alert Bulletin - Hepatitis
... Hepatitis C infection is estimated to be responsible for most chronic liver disease in the United States ... Acquisition of hepatitis C infection is very rapid among new drug injectors ...

Hepatitis C Complete health information regarding HCV on MedicineNet.com
Learn and become aware of Hepatitis C includes a complete description of the virus, transmission, prevention, symptoms, diagnosis, and forms of treatment. ... How does liver damage occur in hepatitis C infection? How is hepatitis C virus spread and how can ... What are the symptoms of hepatitis C infection? What conditions outside the ...

Hepatitis C and Complementary and Alternative Medicine: 2003 Update
... small and on liver diseases rather than on hepatitis C infection specifically, and the results have been contradictory ...

HEPATITIS C TRANSMISSION
... 79-year-old retired ironworker developed a hepatitis C infection that ultimately took his life on ... old retired ironworker developed a hepatitis. C infection that ultimately took his ...

Conclusions About Milk Thistle (Hep C Treatment)


Conclusions About Milk Thistle
A May 2005 review of clinical studies which casts doubt on milk thistle's value has recently been re-released into the press. Alternatively, an extensive amount of research supports the continued usage of this herb at higher dosages. Researchers of the...

Magnetic Resonance Imaging (MRI Scan)
Title: Magnetic Resonance Imaging (MRI Scan)Category: Procedures and TestsCreated: 12/31/1997Last Editorial Review: 8/31/2005

Cirrhosis Of The Liver
Title: Cirrhosis Of The LiverCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 12/1/2005

Fatty Liver
Title: Fatty LiverCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 8/29/2005

SCH 503034 Jumps on the Fast Track
Schering-Plough's oral HCV protease inhibitor, SCH 503034, is in phase II trials, and may make for a better combination with Peg-intron. Check-in with us regularly, as we will be keeping close tabs on this development....

Wednesday, March 01, 2006


Hep C Patent Case Resolved (Hep C Treatment)


Hep C Patent Case Resolved
Red Herring, CA - Feb 10, 2006Belgian biopharmaceutical company Innogenetics has settled a patent lawsuit with Third Wave Technologies over a hepatitis C testing kit, with Third Wave ...

IBTS continues to investigate hep C case
Irish Medical News, Ireland - Feb 10, 2006by Julie-Anne Barnes. The IBTS is continuing its investigation into the case of a 76-year-old Kerry woman who tested positive for the hepatitis C virus. ...

Woman gets hepatitis C after blood transfusions
Irish Examiner, Ireland - Jan 29, 2006... Mr Kelly says it took six months before he was told that all five donors had been traced and retested negative for hep C. Dr Power ...

Health calendar
Asheville Citizen-Times, NC - Feb 21, 2006... HEP C HOPE: State Representative Susan Fisher will discuss health care in North Carolina at 6 pm at MAHEC, 501 Biltmore Ave. Call 350-7500. ...

Serono 4Q Data Is Light On Revenue-JP Morgan
New Ratings - Feb 6, 2006... JP Morgan says it expects an update on how Serono plans to commercialize Rebif, in Asian Hep C patients, in Japanese market at 1400 GMT conference call. ...

Madtown Music Rundown, Sat. Feb 4, 2006: The Steph does Meth ...
Dane101, Wisconsin - Feb 3, 2006Bonnaroo, possibly in an effort to avoid hep-C, has begun booking less String Cheese Incident type acts and managed to snag Radiohead for a headline. ...

HCV Testing (PDF) (Hep C Treatment)


HCV Testing (PDF)
PROGRAM OPERATING PROCEDURES AND STANDARDS. Chapter. 5. HCV Testing. Confidential hepatitis C virus (HCV) testing will be offered to those clients who. are considered highest risk for HCV infection. Portions of the standards were

HCV Wireless
... HCV Wireless converts your vertical market knowledge and requirements into reality using our ... on your core business while HCV Wireless manages your commercialization issues & reduces ...

HIV-HCV Development Meeting Highlights
A Continuing Medical Education Monograph. Expert Perspectives: Strategies for the Management of HIV/HCV Coinfection. DESCRIPTION ... magnitude of the problems of HCV infection and HIV/HCV coinfection. * Describe current standards for HCV treatment and ongoing management ...

What is Chronic HCV?
WHAT IS CHRONIC HEPATITIS C? Chronic hepatitis C is defined as the persistence of HCV RNA in the blood for six months or more. In people with chronic hepatitis C, the immune system has failed to clear the virus from the body. ... C will always have an elevated HCV RNA. Once a person is ...

The Doctor Is In - Treatment and Care for Chronic Hepatitis C ... (Hep C Treatment)


The Doctor Is In - Treatment and Care for Chronic Hepatitis C ...
Questions from Readers and Answers by Medical Experts on Treatment and Care for Chronic Hepatitis C Virus (HCV) Infection ...

HEPATITIS C INFO CENTER - With Daily Hepatitis C Updates
... for decades before being discovered. According to the CDC, 20 to 30% of people with chronic Hepatitis C will eventually face life-threatening symptoms. ...

Chronic Hepatitis C: Current Disease Management
Explains the causes and symptoms of hepatitis C, along with information about diagnosis and treatment.

Hepatitis C Complete health information regarding HCV on ...
Once established, chronic hepatitis C virus infection causes an inflammation of the liver called chronic hepatitis. This condition can progress to scarring ...

Treatment Recommendations for Patients with Chronic Hepatitis C
These guidelines cover the management, assessment, and treatment of veterans with hepatitis C in the VA system.

Is There A Vaccine For Hepatitis C?(NC)-No, not (Hep C Treatment)

Is There A Vaccine For Hepatitis C?

(NC)-No, not for hepatitis C. There are vaccines for hepatitis A and hepatitis B. To prevent further damage to your liver, your doctor may advise you to be vaccinated against hepatitis A and hepatitis B.

Could I give hepatitis C to someone else?

Yes, as far as we know, once you have hepatitis C, you can always transmit it to someone else if they come in contact with your blood. If you have hepatitis C, you can't donate blood. You should avoid sharing personal items like razors and toothbrushes, because the virus is spread through blood to blood contact.

Although the virus isn't spread easily by sexual contact or from a mother to her unborn baby, the risk of transmitting the virus is not absent. Therefore, talk to your doctor first if you want to have children. p>

For more information on hepatitis C visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.


Tuesday, February 28, 2006


Hepatitis C: Early Detection Means Better Health(NC)-Experts estimate (Hep C Treatment)

Hepatitis C: Early Detection Means Better Health

(NC)-Experts estimate that 240,000 people in Canada are currently infected with hepatitis C, of whom only 30% know they have the virus. The only way to find out for sure if you have hepatitis C is through a blood test. Your doctor can order one for you. By taking this action you'll be doing yourself a favour because hepatitis C can be treated only if it has been detected. Untreated hepatitis C can lead to severe conditions that require long-term, intensive care.

For more information visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.



Peregrine Announces Completion of Planned Patient Enrollment and ... (Hep C Treatment)


Peregrine Announces Completion of Planned Patient Enrollment and ...
PR Newswire (press release), NY - Feb 15, 2006- HCV Clinical Expert Dr. John McHutchison Also Joins Peregrine SRB - TUSTIN, Calif., Feb. 15 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. ...

Peregrine Announces Completion of Planned Patient Enrollment and ...
PharmaLive.com (press release), PA - Feb 15, 2006TUSTIN, Calif., February 15, 2006 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. , a biopharmaceutical company with a ...

Peregrine Announces Completion of Planned Patient Enrollment and ...
Yahoo! News (press release) - Feb 15, 2006TUSTIN, Calif., Feb. 15 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM - News), a biopharmaceutical company ...


Treating Chronic Mutational Hepatitis B with Chinese Medicine (Hep C Treatment)

Treating Chronic Mutational Hepatitis B with Chinese Medicine Vitalliver (Vigconic Suppositories)


Treating chronic mutational hepatitis B with Chinese medicine Vitalliver (Vigconic suppositories)


ZHANG GUAN HUA, LIANG CHAO, ZHENG WAN PIN


Chengdu University of TCM, Hepatitis Laboratory in the attached hospital of Chengdu University of TCM, Sichuan, China

Research Method:

Quantitative determination by contrasting HBV-DNA of cases before and after the treatment.

Number of cases: 25 (n)

Case Selection: Between the age of 16 and 65, in accordance with the diagnosis standards pf chronic Hepatitis B, with negative e antigen and positive e antibody, HBV-DNA > 1 104 cp/mL.

Detection Method: All the blood samples are detected by Sichuan Clinical Detection Center; PCR-ELISA quantitative determination is used within detection range of 1 104 - 1 107-8, HBV-DNA, unit of measurement is cp/mL.

Direction Plan: one suppository provided by Vigconic (International) Ltd. Bid. The course of treatment is six months, the tracing observation after withdrawal lasts six months.

Observation index:


  1. HBV-DNA response after the treatment.

  2. Lasting HBV-DNA response (six months after withdrawal).
    p>

Criterion of Therapeutic Effect:


  1. If HBV-DNA volume 1 104 cp/mL: 4/25 (16%)

  2. Lasting response:


HBV-DNA volume 1 104 cp/mL: 2/25 (8%)

Among the results of lasting response, 16 blood serum samples are detected through fluorimetric quantitative determination PCR by the instruments of PE.USD, H-7700 in the second attached hospital of Guangzhou Medical College. The result is in accordance with that in Sichuan Clinical Testing Center. (8 cases among it 1 102 cp/mL). The testing range of this testing method is 1 102 - 1 107-8 cp/mL.

Conclusion

The reason for the repeatedly abnormal liver function of Chronic Hepatitis B (CHB) patients lies in the repeatedly duplication of HBV after infection, which leads to fibrosis of liver, then cirrhosis and liver cancer. It is commonly accepted that if CHB shows the transformation of HBeAg/Anti-HBe, HBV-DNA becoming negative, liver function returning to normal state, the disease is relieved. However, parts of patients with the transformation of HBeAg/Anti-HBe still remain positive in HBV-DNA and the pathological change in the liver continues. Because HBV-DNA occurs promoter mutation in the anterior C section (1896 necleoside G-A variation) or in the C section (1762 nucleoside T variation, 1764 G-A variation), HBeAg cannot come into being. Therefore, the HBeAg in the patient s blood cannot be detected, while the virus can keep on duplicating and fixing itself. Through sequential assay of nucleic acid, it proves that promoter mutation appears in 30%-60% of HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section. In some provinces and cities of the People of China, the percentage of promoter mutation appears in HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section is from 17.6% to 78.9%. Eight out of the 25 cases of our observation go through the sequential assay of nucleic acid carried out by the Department of Microbiology of the University of Hong Kong. It all proves to have HBV-DNA mutation. The chronic mutational Hepatitis B is infectious and apt to cause cirrhosis and liver cancer since the present medicines of antivirus and immuno-modulator do not produce the expected therapeutic effects.

Vitalliver suppository is made up from a formula of Chinese herbs, including Ginseng, Deer Horn, Cordyceps, Radix Astragali, Frudctus Cnidii, Semen Cuscutae, etc. The formula is mainly for strengthening the body resistant and primarily for reinforcing Kidney Qi, which produces good therapeutic effects in treating chronic mutational Hepatitis B. The mechanism is probably that through the regulating of immune system, the duplication of virus is inhibited and meanwhile the liver is protected, so it can produce a lasting therapeutic effect. No adverse reaction and severe accident happens during clinical observation, so it is safe for using. Vitalliver is bringing hopes to the treatment of chronic mutational Hepatitis B.

* The second stage of clinical trial would be carrying out by the Microbiology Department of the University of Hong Kong and Chengdu University of Traditional Chinese Medicine.

For more information, please visit: http://www.vigconic.com


Or, contact:


William Yip cs@vigconic.com
p>
5/F, Cheung Wah Building, Sheung Heung Rd,


Kowloon, Hong Kong


Tel: 852-27656200


Fax: 852-27645314
p>

Chengdu University of TCM, Hepatitis Laboratory in the attached hospital of Chengdu University of TCM, Sichuan, China


webmaster@vigconic.com

Monday, February 27, 2006


Tata Motors: Bumpy ride (Hep C Treatment)


Tata Motors: Bumpy ride
Business Standard India - Feb 09 10:43 AM
Tata Motors operating profit margin dropped by 1.04 basis points y-o-y to 12.28 per cent in the Q3 FY06. Operating profit increased by just 7.22 per cent to Rs 623.06 crore, though net sales have gone up by 16.31 per cent.Save to My Web

Catalyst Biosciences Raises $30 Million Series B Financing to Advance Therapeutic Proteases
[Press Release] PR Newswire via Yahoo! Finance - Feb 09 5:00 AM
Catalyst Biosciences, Inc., a privately held biotechnology company focused on engineering and developing novel therapeutic protease products, today announced it has raised $30 million in its Series B financing.Save to My Web

Notafa age-group athletics open
Sun Star - Feb 24 8:49 PM
ESCALANTE City play host Saturday to the revived monthly track and field age-group competitions of the Negros Occidental Track and Field Association. Competitions would be both in the elementary and secondary divisions.Save to My Web

Scientists Call For Hepatitis Treatment Of Young Injection Drug Users
Medical News Today - Feb 11 8:08 AM
In a recent study published in the journal Clinical Infectious Diseases, scientists from New York City, Baltimore, Seattle, and San Diego called for an immediate public health intervention to treat young injection drug users infected with the hepatitis C virus (HCV). In a careful review of over 400 individuals who tested positive for hepatitis C virus, 96% had conditions which would typically Save to My Web

ViroPharma Licenses Rights to Develop Novel Therapeutic for Treatment of Clostridium Difficile-Associated Disease
[Press Release] PR Newswire via Yahoo! Finance - Feb 27 8:15 AM
ViroPharma Incorporated today announced that the company has entered into a licensing agreement with Dr. Dale N. Gerding, Associate Chief of Staff for Research at the Hines VA Hospital, for the rights to develop non-toxigenic strains of C. difficile for the treatment and prevention of C. difficile-associated disease .Save to My Web

Transition Therapeutics Announces Second Quarter Fiscal 2006 Financial Results
[Press Release] CNW Group via Yahoo! Finance - Feb 14 5:33 AM
Transition Therapeutics Inc. , a biopharmaceutical company focused on developing therapeutics for disease indications with large markets, today announced its financial results for the quarter ended December 31, 2005.Save to My Web

Management of Hepatitis C (CBM 97-1) (Hep C Treatment)


Management of Hepatitis C (CBM 97-1)
Management of Hepatitis C. Last updated: 29 December 2004 First published: 06 June 1997 Metadata| Permanence level: Permanent: Stable Content ...

Hepatitis C
Copyright 1998 Trustees of Dartmouth College. An Important Message from Dr. Koop Contents · Search · Glossary · About the Site.

Hep C Connection
A newsletter for people interested in or suffering from hepatitis C.

VA National Hepatitis C Program
The Veterans Affairs National Hepatitis C Web site provides information about viral hepatitis for health care providers inside and outside the VA system, ...

Hepatitis C: An Epidemic for Anyone
This public health awareness site, hosted by Dr. C. Everett Koop, provides extensive information about hepatitis C and the hepatitis c epidemic.

National Hepatitis C Coalition Inc. - Offering Hope For Hepatitis C
The original nationwide hepatitis C coalition of patients and families, providing education and support through online communications, hep C hotline, ...

Woman gets hepatitis C after blood transfusions (Hep C Treatment)


Woman gets hepatitis C after blood transfusions
Irish Examiner, Ireland - Jan 29, 2006... Mr Kelly says it took six months before he was told that all five donors had been traced and retested negative for hep C. Dr Power ...

Hep C key lies in new needles, not education
Australian, Australia - Feb 19, 2006PROVIDING clean needles to injecting drug users is almost four times more effective in fighting the rising epidemic of hepatitis C than the education and ...

IBTS continues to investigate hep C case
Irish Medical News, Ireland - Feb 10, 2006by Julie-Anne Barnes. The IBTS is continuing its investigation into the case of a 76-year-old Kerry woman who tested positive for the hepatitis C virus. ...

Girl, 7, finds mother dead of overdose
ic Wales, United Kingdom - Jan 27, 2006... Detective Constable Russell Jenkins, of Aberdare police, said that as she was attacked, Ms Howells heard the man say: I ve got hep C and you re going to ...

Broad Hep C push works
The Age, Australia - Feb 19, 2006By Misha Schubert. GIVING free syringes, safety tips and health care to drug users in a broad strategy to curb Australia's hepatitis ...

Treating Chronic Mutational Hepatitis B with Chinese Medicine (Hep C Treatment)

Treating Chronic Mutational Hepatitis B with Chinese Medicine Vitalliver (Vigconic Suppositories)


Treating chronic mutational hepatitis B with Chinese medicine Vitalliver (Vigconic suppositories)


ZHANG GUAN HUA, LIANG CHAO, ZHENG WAN PIN


Chengdu University of TCM, Hepatitis Laboratory in the attached hospital of Chengdu University of TCM, Sichuan, China

Research Method:

Quantitative determination by contrasting HBV-DNA of cases before and after the treatment.

Number of cases: 25 (n)

Case Selection: Between the age of 16 and 65, in accordance with the diagnosis standards pf chronic Hepatitis B, with negative e antigen and positive e antibody, HBV-DNA > 1 104 cp/mL.

Detection Method: All the blood samples are detected by Sichuan Clinical Detection Center; PCR-ELISA quantitative determination is used within detection range of 1 104 - 1 107-8, HBV-DNA, unit of measurement is cp/mL.

Direction Plan: one suppository provided by Vigconic (International) Ltd. Bid. The course of treatment is six months, the tracing observation after withdrawal lasts six months.

Observation index:


  1. HBV-DNA response after the treatment.

  2. Lasting HBV-DNA response (six months after withdrawal).
    p>

Criterion of Therapeutic Effect:


  1. If HBV-DNA volume 1 104 cp/mL: 4/25 (16%)

  2. Lasting response:


HBV-DNA volume 1 104 cp/mL: 2/25 (8%)

Among the results of lasting response, 16 blood serum samples are detected through fluorimetric quantitative determination PCR by the instruments of PE.USD, H-7700 in the second attached hospital of Guangzhou Medical College. The result is in accordance with that in Sichuan Clinical Testing Center. (8 cases among it 1 102 cp/mL). The testing range of this testing method is 1 102 - 1 107-8 cp/mL.

Conclusion

The reason for the repeatedly abnormal liver function of Chronic Hepatitis B (CHB) patients lies in the repeatedly duplication of HBV after infection, which leads to fibrosis of liver, then cirrhosis and liver cancer. It is commonly accepted that if CHB shows the transformation of HBeAg/Anti-HBe, HBV-DNA becoming negative, liver function returning to normal state, the disease is relieved. However, parts of patients with the transformation of HBeAg/Anti-HBe still remain positive in HBV-DNA and the pathological change in the liver continues. Because HBV-DNA occurs promoter mutation in the anterior C section (1896 necleoside G-A variation) or in the C section (1762 nucleoside T variation, 1764 G-A variation), HBeAg cannot come into being. Therefore, the HBeAg in the patient s blood cannot be detected, while the virus can keep on duplicating and fixing itself. Through sequential assay of nucleic acid, it proves that promoter mutation appears in 30%-60% of HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section. In some provinces and cities of the People of China, the percentage of promoter mutation appears in HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section is from 17.6% to 78.9%. Eight out of the 25 cases of our observation go through the sequential assay of nucleic acid carried out by the Department of Microbiology of the University of Hong Kong. It all proves to have HBV-DNA mutation. The chronic mutational Hepatitis B is infectious and apt to cause cirrhosis and liver cancer since the present medicines of antivirus and immuno-modulator do not produce the expected therapeutic effects.

Vitalliver suppository is made up from a formula of Chinese herbs, including Ginseng, Deer Horn, Cordyceps, Radix Astragali, Frudctus Cnidii, Semen Cuscutae, etc. The formula is mainly for strengthening the body resistant and primarily for reinforcing Kidney Qi, which produces good therapeutic effects in treating chronic mutational Hepatitis B. The mechanism is probably that through the regulating of immune system, the duplication of virus is inhibited and meanwhile the liver is protected, so it can produce a lasting therapeutic effect. No adverse reaction and severe accident happens during clinical observation, so it is safe for using. Vitalliver is bringing hopes to the treatment of chronic mutational Hepatitis B.

* The second stage of clinical trial would be carrying out by the Microbiology Department of the University of Hong Kong and Chengdu University of Traditional Chinese Medicine.

For more information, please visit: http://www.vigconic.com


Or, contact:


William Yip cs@vigconic.com
p>
5/F, Cheung Wah Building, Sheung Heung Rd,


Kowloon, Hong Kong


Tel: 852-27656200


Fax: 852-27645314
p>

Chengdu University of TCM, Hepatitis Laboratory in the attached hospital of Chengdu University of TCM, Sichuan, China


webmaster@vigconic.com


Hepatitis C - silent epidemic (Hep C Treatment)


Hepatitis C - silent epidemic
Thunder Bay's Source, Canada - Feb 23, 2006The incidence of Hepatitis C is rising in Northwestern Ontario, and alarmingly, at a much higher rate than the rest of the province. ...

Despite Heightened Concerns Over Influenza, the Most Commercially ...
Infection Control Today, AZ - Feb 22, 2006-- Decision Resources, Inc., a leading research and advisory firm focusing on pharmaceutical and healthcare issues, finds that HIV, hepatitis C, and hepatitis ...

Aethlon CEO to Present at Today's Bird Flu Summit
Genetic Engineering News, NY - 3 hours ago... resistant bioweapons, naturally evolving pandemic threats such as H5N1 Avian Flu, and chronic infectious disease targets including Hepatitis-C (HCV) and the ...

Sunday, February 26, 2006


USDA Funded Projects (Hep C Treatment)


USDA Funded Projects
... disease distribution will be applied to newly emeerged diseases such as postweaning multisystemic wasting syndrome and Michigan rabbit viral heaptitis. ...

Observation of lipid profile and lipoproteins in viral hepatitis ...
VLDL levels were significantly decreased in patients of viral heaptitis (22.13 �8 mg/dl) as well as on viral hepatitis with coma (21.89 �3 mg/dl). ...

Hepatitis C Infection
Institute of Viral Heaptitis, First Affiliated Hospital, WCUMS, Chengdu 610041. ... Coinfection HIV & Viral Heaptitis: a. guide. December 2003. ...

VIRAL HEPATITIS :: intern.nicejelly.com :: Viral Hepatitis
... viral hepa5titis, viral hepa6itis, viral heaptitis, viral hep0atitis, vi9ral hepatitis, fviral hepatitis, viral hepatitisw, viral hepatitias, ...

Peregrine Announces Completion of Planned Patient Enrollment and ... (Hep C Treatment)


Peregrine Announces Completion of Planned Patient Enrollment and ...
PharmaLive.com (press release), PA - Feb 15, 2006TUSTIN, Calif., February 15, 2006 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. , a biopharmaceutical company with a ...

Peregrine Announces Completion of Planned Patient Enrollment and ...
Yahoo! News (press release) - Feb 15, 2006TUSTIN, Calif., Feb. 15 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM - News), a biopharmaceutical company ...

Peregrine Announces Completion of Planned Patient Enrollment and ...
PR Newswire (press release), NY - Feb 15, 2006- HCV Clinical Expert Dr. John McHutchison Also Joins Peregrine SRB - TUSTIN, Calif., Feb. 15 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. ...